<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00459914</url>
  </required_header>
  <id_info>
    <org_study_id>FUCAP2004</org_study_id>
    <nct_id>NCT00459914</nct_id>
  </id_info>
  <brief_title>Sleep Apnea and Refractory Hypertension: Prevalence and Effect of CPAP Treatment</brief_title>
  <official_title>Sleep Apnea in Patients With Refractory Hypertension: Study of the Prevalence and the Effect of CPAP Treatment on Blood Pressure Control, Endothelial Dysfunction and Angiogenesis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacio Catalana de Pneumologia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundacio Catalana de Pneumologia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A small number of uncontrolled studies have shown a high prevalence of sleep apnea in
      patients with refractory hypertension and that CPAP treatment achieves a significant
      reduction of blood pressure in the short term.

      The purpose of this study is to assess the prevalence of sleep apnea in patients with
      refractory hypertension, and the effects of continuous positive pressure treatment on
      systemic blood pressure and on serum markers of endothelial dysfunction and angiogenesis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We assess the prevalence of an apnea hypopnea index (AHI) &gt; 5 in patients with refractory
      hypertension referred from a hypertension clinic. Patients with an AHI &gt;15 are randomized to
      either continuing their usual pharmacological treatment alone or adding CPAP to their usual
      treatment, during a 3 month period.

      The main endpoint is the comparison of the mean 24h systolic and diastolic blood pressure, as
      assessed by ambulatory blood pressure monitoring, between both treatment arms. The secondary
      endpoint is to assess changes in serum markers of endothelial dysfunction and angiogenesis
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of 3 months of CPAP versus conventional pharmacological treatment on the mean 24 h systolic and diastolic blood pressure .</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of CPAP versus conventional pharmacological treatment on inflammatory, endothelial function and angiogenesis serum biomarkers</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>Hypertension</condition>
  <condition>Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>1 CPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nasal continuous positive airway pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Pharmacological treatment alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cpap treatment during sleep</intervention_name>
    <description>CPAP</description>
    <arm_group_label>1 CPAP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients referred from a tertiary hospital hypertension clinic with a diagnosis of
             refractory hypertension on the basis of office blood pressure higher then 160/90 mmHg
             despite the recommended doses of at least 3 drugs, including a diuretic.

        Exclusion Criteria:

          -  Causes of secondary hypertension, history of alcohol abuse , renal insufficiency,
             severe chronically illness.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lourdes Lozano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General Universitari Vall d'Hebron</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Luis Tovar, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital General Universitari Vall d'Hebron</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gabriel Sampol, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital General Universitari Vall d'Hebron</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Odile Romero, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital General Universitari Vall d'Hebron</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pilar Chacon, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital General Universitari Vall d'Hebron</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Rios</last_name>
    <role>Study Chair</role>
    <affiliation>Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Servei de Pneumologia, Hosital general Universitari Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2007</study_first_submitted>
  <study_first_submitted_qc>April 11, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 13, 2007</study_first_posted>
  <last_update_submitted>January 27, 2009</last_update_submitted>
  <last_update_submitted_qc>January 27, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 29, 2009</last_update_posted>
  <responsible_party>
    <name_title>Ferran Morell</name_title>
    <organization>Fundacio Catalana de Pneumologia</organization>
  </responsible_party>
  <keyword>sleep apnea</keyword>
  <keyword>refractory hypertension</keyword>
  <keyword>continuous positive airway pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

